Biotech Company Tigenix Plans to Sell Dutch Manufacturing Facility

Belgian biotech company TiGenix is planning to sell its manufacturing facility in Sittard-Geleen, the Netherlands.

The company said it is in advanced talks with a number of parties to sell the facility, Reuters reports Tuesday.

.

TiGenix said the renewal of its license for the plant by Dutch authorities had allowed it to move ahead with talks on selling the facility while continuing to make its drugs there.